Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine for acute pain after hemorrhoidectomy (real-world observational cohort)
ChiCTR2400088883Phase 4Recruiting
- Sponsor
- Nanjing Municipal Hospital of Traditional Chinese Medicine
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bupivacaine in postoperative pain (2 cohorts), sponsored by Nanjing Municipal Hospital of Traditional Chinese Medicine. Primary endpoint: Proportion of patients with NRS score ≤3 at rest within 72 hours after surgery. Started Aug 2024; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400088883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088883.